GRI Bio, Inc.
GRI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001824293
No open-market purchases or sales by GRI Bio, Inc. insiders were filed in the last 90 days; 11 institutions reported holding it in 13F filings for Q2 2026, worth $164.7K in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in GRI Bio, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 11
- +1 vs. Q1 2021
- Shares held
- 579.3K
- +52.8K (+10.0%) vs. Q1 2021
- Total value
- $3.15M
- +$711.0K (+29.2%) vs. Q1 2021
- New holders
- 5
- 2 more added
- Sold out
- 4
- 1 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GRI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 11 | $164.7K |
| Q1 2026 | 6 | $64.7K |
| Q4 2025 | 7 | $14.7K |
| Q3 2025 | 8 | $276.8K |
| Q2 2025 | 5 | $25.3K |
| Q1 2025 | 5 | $15.5K |
| Q4 2024 | 8 | $185.2K |
| Q3 2024 | 7 | $49.7K |
| Q2 2024 | 5 | $139.7K |
| Q1 2024 | 6 | $177.2K |
| Q4 2023 | 9 | $82.8K |
| Q3 2023 | 6 | $887.2K |
| Q2 2023 | 5 | $5.09M |
| Q1 2023 | 9 | $37.4K |
| Q4 2022 | 13 | $88.5K |
| Q3 2022 | 8 | $74.0K |
| Q2 2022 | 10 | $141.0K |
| Q1 2022 | 13 | $765.0K |
| Q4 2021 | 13 | $2.86M |
| Q3 2021 | 12 | $2.75M |
| Q2 2021 | 11 | $3.15M |
| Q1 2021 | 10 | $2.44M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding GRI Bio, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Murchinson Ltd. | 194,900 | $1.06M | 0.39% | +194,900 | New |
| Altium Capital Management LP | 161,440 | $878.0K | 0.20% | −138,560−46.2% | Reduced |
| Ikarian Capital, LLC | 140,000 | $761.0K | 0.14% | 00.0% | Unchanged |
| Zeke Capital Advisors, LLC | 30,000 | $163.0K | 0.01% | +30,000 | New |
| Envestnet Asset Management Inc | 17,513 | $95.0K | 0.00% | +5,737+48.7% | Added |
| Boothbay Fund Management, LLC | 17,099 | $93.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 13,116 | $71.0K | 0.00% | +13,116 | New |
| Advisor Group Holdings, Inc. | 4,378 | $24.0K | 0.00% | +2,251+105.8% | Added |
| UBS Group AG | 813 | $4.00K | 0.00% | +813 | New |
| Wells Fargo & Company | 14 | $0 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 17 | $0 | 0.00% | +17 | New |
| Millennium Management LLC | 0 | $0 | 0.00% | −28,461−100.0% | Sold out |
| AIGH Capital Management LLC | 0 | $0 | 0.00% | −20,514−100.0% | Sold out |
| Sowell Financial Services LLC | 0 | $0 | 0.00% | −5,868−100.0% | Sold out |
| BlackRock Inc. | 0 | $0 | 0.00% | −641−100.0% | Sold out |